| Name | BCR-ABL-IN-1 |
|---|
| Description | BCR-ABL-IN-1 is an inhibitor of BCR-ABL tyrosine kinase, with a pIC50 of 6.46, and may be used in the research of chronic myelogenous leukemia. |
|---|---|
| Related Catalog | |
| Target |
pIC50: 6.46 (BCR-ABL)[1] |
| In Vitro | BCR-ABL-IN-1 (Compound 21) is an inhibitor of BCR-ABL tyrosine kinase, with a pIC50 of 6.46, and may be used in the research of chronic myelogenous leukemia. |
| References |
| Molecular Formula | C23H21F4N5O |
|---|---|
| Molecular Weight | 459.44 |
| Storage condition | 2-8℃ |